Literature DB >> 8027060

Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists.

M E Olah1, K A Jacobson, G L Stiles.   

Abstract

The bovine A1 adenosine receptor (A1AR) and rat A3 adenosine receptor (A3AR) display distinct agonist and antagonist binding properties. To identify regions involved in ligand recognition, A1AR/A3AR chimeric receptors were created, expressed in COS-7 cells, and analyzed by radioligand binding. A chimeric receptor in which the third intracellular loop of the A1AR was replaced with that of the A3AR bound agonists and the antagonist, [3H]xanthine amine congener, with affinities identical to wild-type A1AR. A chimeric receptor with the fifth transmembrane domain (TM5) and third intracellular loop of the A1AR replaced with that of the A3AR displayed antagonist affinity similar to wild-type A1AR. However, relative to the A1AR, this chimeric demonstrated much greater affinity for 5'-substituted adenosine analogs, whereas affinity for N6-substituted compounds was unaffected. Substitution of a 6-amino acid cassette of the exofacial half of TM5 of the A3AR into the A1AR produced enhanced binding of exclusively a 5'-substituted analog, indicating involvement of this specific region in ligand recognition. These findings suggest that the 5'- and N6-substituents of adenosine agonists bind to distinct regions of ARs and that TM5 of the A3AR interacts more favorably with 5'-substituted compounds than does that of the A1AR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027060      PMCID: PMC5470540     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.

Authors:  A P IJzerman; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1992

2.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.

Authors:  M E Olah; H Ren; J Ostrowski; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

3.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

5.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.

Authors:  K N Klotz; M J Lohse; U Schwabe
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

7.  Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.

Authors:  J Linden; H E Taylor; A S Robeva; A L Tucker; J H Stehle; S A Rivkees; J S Fink; S M Reppert
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

8.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

10.  The probable arrangement of the helices in G protein-coupled receptors.

Authors:  J M Baldwin
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more
  7 in total

1.  Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.

Authors:  Q Jiang; B X Lee; M Glashofer; A M van Rhee; K A Jacobson
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

2.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

Authors:  Q Jiang; A M Van Rhee; J Kim; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

3.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

4.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

5.  Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.

Authors:  J Kim; Q Jiang; M Glashofer; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-04       Impact factor: 4.436

6.  Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.

Authors:  J Kim; J Wess; A M van Rhee; T Schöneberg; K A Jacobson
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

Review 7.  The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.

Authors:  Joana Beatriz Sousa; Carmen Diniz
Journal:  Molecules       Date:  2017-05-06       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.